SARS-CoV-2 Nanovaccine Composed of Microfluidic-Produced Gold Nanoparticles Induces Neutralizing Immune Responses-Reference-Cited by-同舟云学术

SARS-CoV-2 Nanovaccine Composed of Microfluidic-Produced Gold Nanoparticles Induces Neutralizing Immune Responses

Published:2023-12-05 Issue:24 Volume:6 Page:22774-22783
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Dalibera Natália Cristina¹²^ORCID,Rodrigues-Jesus Monica Josiane³⁴^ORCID,Andreata-Santos Robert³⁵^ORCID,Ramos Janini Luiz Mário⁵^ORCID,Oliveira Aline Furtado²^ORCID,Rodrigues Azzoni Adriano¹^ORCID,de Souza Ferreira Luís Carlos³^ORCID,Favaro Marianna T. P.³⁶^ORCID

Affiliation:

1. Departamento de Engenharia Química, Escola Politécnica, Universidade de São Paulo, Av. Prof. Luciano Gualberto, Trav. 3, N° 380, Butantã, CEP 05508-900 São Paulo, SP, Brazil

2. Unidade de Negócios Bionanomanufatura, Laboratório de Processos Químicos e Tecnologia de Partículas, Instituto de Pesquisas Tecnológicas de São Paulo - IPT, Av. Prof. Almeida Prado, 532, Butantã, CEP 05508-901 São Paulo, SP, Brazil

3. Laboratório de Desenvolvimento de Vacinas, Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Av. Prof. Lineu Prestes, 2415, Butantã, CEP 05508-000 São Paulo, SP, Brazil

4. Division of Infectious Diseases and International Health, University of Virginia, 345 Crispell Drive, MR-6, 22908 Charlottesville, Virginia, United States

5. Retrovirology Laboratory, Department of Microbiology, Immunology and Parasitology, Paulista School of Medicine, Federal University of São Paulo (UNIFESP), 04021-001 São Paulo, SP, Brazil

6. Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain

Funder

Minist??rio da Ci??ncia, Tecnologia e Inova????o

Funda????o de Amparo ?? Pesquisa do Estado de S??o Paulo

Coordena????o de Aperfei??oamento de Pessoal de N??vel Superior

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.3c03905

Reference45 articles.

1. SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic

2. An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines

3. A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project

4. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

5. Gold nanoparticle-based platforms for vaccine development

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Layer-by-Layer Assembly of Polymeric Nanoparticles with Heparin-RBD Complexes as an Adjuvant for SARS-CoV-2 Protein-Based Vaccines;ACS Applied Nano Materials;2024-02-06